🔗 Share this article

Following a delay and an unusually contentious meeting, a government vaccine expert group was expected to vote on Friday regarding a potential change to the longstanding recommendation that each baby be vaccinated against hepatitis B.

Fiery Exchange and a Postponed Decision

The first day of the assembly on Thursday was characterized by heated debate over restricting access to the hepatitis B vaccine for babies and a choice to delay the ballot by a day to provide committee members extra time to review the wording. The group, which counsels the Centers for Disease Control and Prevention on vaccine use, had previously delayed on two occasions.

“Is there any definitive data of damage of giving this immunization before 30 days? Or is this speculation?” asked one adviser.

In reply, another attendee stated, “There is scant proof about the long-term risk.”

Existing Recommendations and Possible Consequences

The injection is currently suggested for every newborn within 24 hours of delivery to stop transmission of hepatitis B, which can result in serious liver damage. It has been administered to over a billion individuals for in excess of thirty years.

The Atlanta conference offered no fresh data of injuries resulting from the vaccine. Specialists note any alteration to the existing hepatitis B immunization timeline could have significant and far-reaching repercussions for childhood health in the United States.

Panel Composition and Latest Shifts

The consultative group can only offer guidance to the leader of the CDC. The group's roster has undergone changes recently, with the declaration that the group's former head would step down for an official role and be succeeded by a cardiologist who has been skeptical about other vaccines.

The panel includes multiple vaccination critics who align with a goal to reform – and potentially, in some cases, eliminate – longstanding vaccination recommendations.